• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚砂拉越地区血液系统恶性肿瘤的流行病学(1996 年至 2015 年)。

The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015).

机构信息

Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak (UNIMAS), 94300, Kota Samarahan, Sarawak, Malaysia.

Department of Community Medicine and Public Health, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak (UNIMAS), Kota Samarahan, Sarawak, Malaysia.

出版信息

BMC Cancer. 2023 Jun 19;23(1):563. doi: 10.1186/s12885-023-10988-y.

DOI:10.1186/s12885-023-10988-y
PMID:37337159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10278303/
Abstract

BACKGROUND

Published epidemiological studies of haematological cancers are few. Hereby we present a 20-year epidemiological data of haematological cancers in Sarawak from a population-based cancer registry.

METHODS

Haematological cancer cases with ICD-10 coded C81-C96 and ICD-O coded /3 diagnosed from 1996 to 2015 were retrieved from Sarawak Cancer Registry. Adult was defined as those 15 years and above. Incidence rate (IR) was calculated based on yearly Sarawak citizen population stratified to age, gender, and ethnic groups. Age-standardised IR (ASR) was calculated using Segi World Standard Population.

RESULTS

A total of 3,947 cases were retrieved and analysed. ASR was 10 and male predominance (IR ratio 1.32, 95%CI 1.24,1.41). Haematological cancers generally had a U-shaped distribution with lowest IR at age 10-14 years and exponential increment from age 40 years onwards, except acute lymphoblastic leukaemia (ALL) with highest IR in paediatric 2.8 versus adult 0.5. There was a significant difference in ethnic and specific categories of haematological cancers, of which, in general, Bidayuh (IR ratio 1.13, 95%CI 1.00, 1.27) and Melanau (IR ratio 0.54, 95%CI 0.45, 0.65) had the highest and lowest ethnic-specific IR, respectively, in comparison to Malay. The ASR (non-Hodgkin lymphoma, acute myeloid leukaemia, ALL, chronic myeloid leukaemia, and plasma cell neoplasm) showed a decreasing trend over the 20 years, -2.09 in general, while Hodgkin lymphoma showed an increasing trend of + 2.80. There was crude rate difference between the 11 administrative divisions of Sarawak.

CONCLUSIONS

This study provided the IR and ASR of haematological cancers in Sarawak for comparison to other regions of the world. Ethnic diversity in Sarawak resulted in significant differences in IR and ASR.

摘要

背景

发表的血液系统恶性肿瘤的流行病学研究较少。本文报告了从基于人群的癌症登记处获得的沙捞越地区 20 年来血液系统恶性肿瘤的流行病学数据。

方法

从沙捞越癌症登记处检索了 1996 年至 2015 年间 ICD-10 编码为 C81-C96 和 ICD-O 编码为 /3 的血液系统恶性肿瘤病例。成人定义为 15 岁及以上。发病率(IR)按年龄、性别和种族分层的每年沙捞越公民人口计算。使用 Segi 世界标准人口计算年龄标准化发病率(ASR)。

结果

共检索到 3947 例病例进行分析。ASR 为 10,男性居多(IR 比 1.32,95%CI 1.24,1.41)。血液系统恶性肿瘤的分布一般呈 U 型,10-14 岁时发病率最低,40 岁后呈指数增长,除急性淋巴细胞白血病(ALL)外,儿科发病率最高(2.8 比成人 0.5)。血液系统恶性肿瘤在种族和特定类别方面存在显著差异,一般来说,与马来人相比,比达尤(IR 比 1.13,95%CI 1.00,1.27)和梅拉瑙(IR 比 0.54,95%CI 0.45,0.65)的种族特异性发病率最高和最低。20 年来,ASR(非霍奇金淋巴瘤、急性髓细胞白血病、ALL、慢性髓细胞白血病和浆细胞瘤)呈下降趋势,总体下降 2.09%,而霍奇金淋巴瘤呈上升趋势,增长 2.80%。沙捞越 11 个行政区之间存在粗率差异。

结论

本研究提供了沙捞越地区血液系统恶性肿瘤的发病率和年龄标准化发病率,以便与世界其他地区进行比较。沙捞越的种族多样性导致发病率和年龄标准化发病率存在显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/d595e9b90f96/12885_2023_10988_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/d793f04b7469/12885_2023_10988_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/bbc548ff390f/12885_2023_10988_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/7e0e5edd6bac/12885_2023_10988_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/66ebd7741718/12885_2023_10988_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/16ea68491967/12885_2023_10988_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/d595e9b90f96/12885_2023_10988_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/d793f04b7469/12885_2023_10988_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/bbc548ff390f/12885_2023_10988_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/7e0e5edd6bac/12885_2023_10988_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/66ebd7741718/12885_2023_10988_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/16ea68491967/12885_2023_10988_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff01/10278303/d595e9b90f96/12885_2023_10988_Fig6_HTML.jpg

相似文献

1
The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015).马来西亚砂拉越地区血液系统恶性肿瘤的流行病学(1996 年至 2015 年)。
BMC Cancer. 2023 Jun 19;23(1):563. doi: 10.1186/s12885-023-10988-y.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Epidemiology of Uterine Cancer in Sarawak, Borneo, A 20-Year Review.沙捞越、婆罗洲的子宫癌流行病学:20 年回顾。
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1143-1153. doi: 10.31557/APJCP.2024.25.4.1143.
4
Epidemiology of Nasopharyngeal Carcinoma in Sarawak, East Malaysia.马来西亚沙捞越州鼻咽癌的流行病学。
Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2817-2822. doi: 10.31557/APJCP.2023.24.8.2817.
5
High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island.婆罗洲岛砂拉越原住民鼻咽癌的高发病率。
Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):482-6.
6
[Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].[血液系统恶性肿瘤:1997 - 2004年法国下诺曼底地区的发病率]
Rev Epidemiol Sante Publique. 2009 Jun;57(3):151-8. doi: 10.1016/j.respe.2009.02.204. Epub 2009 Apr 17.
7
The epidemiology of chronic myeloid leukaemia in southern Sarawak, Borneo Island.婆罗洲岛砂拉越南部慢性髓性白血病的流行病学
Med J Malaysia. 2018 Apr;73(2):78-85.
8
[Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].[1983年至2012年间匈牙利绍莫吉-萨博尔奇-贝拉格州成年人血液系统恶性肿瘤的发病率。三十年数据的分析]
Orv Hetil. 2013 Nov 24;154(47):1858-64. doi: 10.1556/OH.2013.29754.
9
Distribution pattern and prevalence of haematological cancers among adults in Abakaliki, South-Eastern Nigeria.尼日利亚东南部阿巴卡利基成年人血液系统癌症的分布模式及患病率
Niger Postgrad Med J. 2021 Oct-Dec;28(4):266-272. doi: 10.4103/npmj.npmj_636_21.
10
Changing causes of death in persons with haematological cancers 1975-2016.1975-2016 年血液系统癌症患者死因变化。
Leukemia. 2022 Jul;36(7):1850-1860. doi: 10.1038/s41375-022-01596-z. Epub 2022 May 16.

引用本文的文献

1
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population.慢性髓性白血病(CML)患者一级亲属中 BCR::ABL1 携带率高于正常人群。
BMC Cancer. 2024 Jun 14;24(1):734. doi: 10.1186/s12885-024-12102-2.

本文引用的文献

1
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版:髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
2
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版:淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
3
Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018.
韩国血液系统恶性肿瘤的20年发病趋势:1999 - 2018年
Blood Res. 2021 Dec 31;56(4):301-314. doi: 10.5045/br.2021.2021187.
4
Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factors.马来西亚砂拉越比达友族的鼻咽癌:历史与风险因素
Oncol Lett. 2021 Jul;22(1):514. doi: 10.3892/ol.2021.12775. Epub 2021 May 6.
5
Leukemia incidence trends at the global, regional, and national level between 1990 and 2017.1990年至2017年间全球、区域和国家层面的白血病发病率趋势。
Exp Hematol Oncol. 2020 Jun 19;9:14. doi: 10.1186/s40164-020-00170-6. eCollection 2020.
6
Global patterns and trends in the incidence of non-Hodgkin lymphoma.非霍奇金淋巴瘤发病率的全球模式与趋势
Cancer Causes Control. 2019 May;30(5):489-499. doi: 10.1007/s10552-019-01155-5. Epub 2019 Mar 20.
7
Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain.基于人群的淋巴肿瘤发病率:西班牙赫罗纳省 20 年的流行病学数据。
Cancer Epidemiol. 2019 Feb;58:8-11. doi: 10.1016/j.canep.2018.11.001. Epub 2018 Nov 10.
8
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.多发性骨髓瘤全球负担:2016 年全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Sep 1;4(9):1221-1227. doi: 10.1001/jamaoncol.2018.2128.
9
The epidemiology of chronic myeloid leukaemia in southern Sarawak, Borneo Island.婆罗洲岛砂拉越南部慢性髓性白血病的流行病学
Med J Malaysia. 2018 Apr;73(2):78-85.
10
Haplotype diversity of 17 Y-chromosomal STRs in three native Sarawak populations (Iban, Bidayuh and Melanau) in East Malaysia.东马来西亚砂拉越三个本地族群(伊班族、比达友族和海达雅族)中17个Y染色体短串联重复序列的单倍型多样性
Forensic Sci Int Genet. 2009 Jun;3(3):e77-80. doi: 10.1016/j.fsigen.2008.07.007. Epub 2008 Sep 10.